Anakinra in Creutzfeldt-Jakob disease

Acta Neurol Belg. 2023 Apr;123(2):705-707. doi: 10.1007/s13760-022-01993-2. Epub 2022 May 31.

Authors

Giuseppe Bomboi¹, Maria Laura Bernardo², Daniele Mei³, Nicola P Falcone³, Mauro Vannicola²

Affiliations

¹ Department of Medicine, Tarquinia Hospital, Viterbo Local Health Authority, Viale Igea, 1, 01016, Tarquinia, VT, Italy. giuseppe.bomboi@asl.vt.it.
² Department of Medicine, Tarquinia Hospital, Viterbo Local Health Authority, Viale Igea, 1, 01016, Tarquinia, VT, Italy.
³ Department of Neurology, Belcolle Hospital, Viterbo Local Health Authority, Viterbo, Italy.

PMID: 35639257
DOI: 10.1007/s13760-022-01993-2

No abstract available

Publication types

Letter

MeSH terms

Creutzfeldt-Jakob Syndrome* / diagnostic imaging
Creutzfeldt-Jakob Syndrome* / drug therapy
Humans
Interleukin 1 Receptor Antagonist Protein / therapeutic use

Substances

Interleukin 1 Receptor Antagonist Protein